Epalrestat, an aldose reductase inhibitor, reduces the levels of N(ε)-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients

Diabetes Care

Volumn 23, Issue 10, 2000, Pages 1539-1544

  Hamada, Yoji ^a   Nakamura, Jiro ^a   Naruse, Keiko ^a   Komori, Taku ^a   Kato, Koichi ^a   Kasuya, Yasuhide ^a   Nagai, Ryuji ^b   Horiuchi, Seikoh ^b   Hotta, Nigishi ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; ALDEHYDE REDUCTASE; ALDOSE REDUCTASE INHIBITOR; DEOXYGLUCOSE; EPALRESTAT; FRUCTOSE; HEMOGLOBIN A1C; SORBITOL; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; FEMALE; HEMOGLOBIN DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS;

EID: 0033803537     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.23.10.1539     Document Type: Article

References (57)

1. Advanced protein glycosylation in diabetes and aging
2. Accumulation of Maillard reaction products in skin collagen in diabetes and aging
3. Glycoxidation in aortic collagen from STZ-induced diabetic rats and its relevance to vascular damage
4. Advanced glycosylation end products in patients with diabetic nephropathy
5. Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM
6. Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency
7. Toxicity of mildly modified low-density lipoproteins to cultured retinal capillary endothelial cells and pericytes
8. Advanced glycation end products interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice: A potential mechanism for the accelerated vasculopathy of diabetes
9. Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: Relevance of glycated collagen products versus HbA(1c) as markers of diabetic complications: DCCT Skin Collagen Ancillary Study Group: Diabetes Control and Complications Trial
10. Site-specific and random fragmentation of Cu,Zn-superoxide dismutase by glycation reaction: Implication of reactive oxygen species
11. Increased glycated Cu,Zn-superoxide dismutase levels in erythrocytes of patients with insulin-dependent diabetes mellitus
12. Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity: A model for intracellular glycosylation in diabetes
13. DNA damage by the glycation products of glyceraldehyde 3-phosphate and lysine
14. DNA cleavage induced by glycation of Cu,Zn-superoxide dismutase
15. Reducing sugars trigger oxidative modification and apoptosis in pancreatic beta-cells by provoking oxidative stress through the glycation reaction
16. Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation, and oxidant-induced apoptosis
17. Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product N(ε)-(carboxymethyl) lysine independently of glycohaemoglobin concentrations
18. Rapid formation of advanced glycation end products by intermediate metabolites of glycolytic pathway and polyol pathway
19. New approaches for treatment in diabetes: Aldose reductase inhibitors
20. Identification of fructose-3-phosphate in the lens of diabetic rats
21. Hyperglycemic pseudohypoxia and diabetic complications
22. 2 in human umbilical vein endothelial cells cultured in high glucose medium
23. Suppression of pentosidine formation in galactosemic rat lens by an inhibitor of aldose reductase
24. Administration of an aldose reductase inhibitor induces a decrease of collagen fluorescence in diabetic rats
25. Tissue-specific effects of aldose reductase inhibition on fluorescence and cross-linking of extracellular matrix in chronic galactosemia: Relationship to pentosidine cross-links
26. N(ε)-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins
27. N(ε)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction
28. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
29. Immunochemical approach to characterize advanced glycation end products of the Maillard reaction
30. Increase in 3-deoxyglucosone levels in diabetic rat plasma: Specific in vivo determination of intermediate in advanced Maillard reaction
31. Determination of D-sorbitol in human erythrocytes by an improved enzymatic method with fluorometric detection
32. D-fructose
33. D-fructose 1,6-bisphospbate,dihydroxyacetone phosphate and D-glyceraldehyde 3-phosphate
34. The stimulatory effects of carbon tetrachloride and other halogenoalkanes on peroxidative reactions in rat liver fractions in vitro: General features of the systems used
35. Nonenzymatic glycosylation and the pathogenesis of diabetic complications
36. Mechanism of autoxidative glycosylation: Identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose
37. Role of oxidative stress in diabetic complications: A new perspective on an old paradigm
38. Hydroxyl radical mediates N(ε)-(carboxymethyl)lysine formation from Amadori product
39. Lipid advanced glycosylation: Pathway for lipid oxidation in vivo
40. Metabolic and vascular factors in the pathogenesis of diabetic neuropathy
41. The formation of methylglyoxal from triose phosphates: Investigation using a specific assay for methylglyoxal
42. N(ε)-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins
43. Metabolic alterations in the human erythrocyte produced by increases in glucose concentration: The role of the polyol pathway
44. Elevated glucose levels increase retinal glycolysis and sorbitol pathway metabolism: Implications for diabetic retinopathy
45. Modification of the glyoxalase system in streptozotocin-induced diabetic rats: Effect of the aldose reductase inhibitor statil
46. 31p NMR spectroscopy
47. Effects of glycemic control on plasma 3-deoxyglucosone levels in NIDDM patients
48. Effects of an aldose reductase inhibitor on erythrocyte fructose 3-phosphate and sorbitol 3-phosphate levels in diabetic patients
49. Mechanism of formation of Maillard protein cross-link pentosidine
50. Effect of an aldose reductase inhibitor (sorbinil) on integration of polyol pathway, pentose phosphate pathway, and glycolytic route in diabetic rat lens
51. 31P-nuclear magnetic resonance evidence of an activated hexosemonophosphate shunt in hyperglycemic rat lenses in vivo
52. Red cell sorbitol: An indicator of diabetic control
53. Clinical analysis of aldose reductase for differential diagnosis of the pathogenesis of diabetic complications
54. Association of erythrocyte aldose reductase activity with diabetic complications in type 1 diabetes mellitus
55. Reduction of trioses by NADPH-dependent aldo-keto reductases: Aldose reductase, methyglyoxal, and diabetic complications
56. Inhibition of aldehyde reductase by aldose reductase inhibitors
57. Monkey 3-deoxyglucosone reductase: Tissue distribution and purification of three multiple forms of the kidney enzyme that are identical with dihydrodiol dehydrogenase, aldehyde reductase, and aldose reductase